Prologis Inc vs Tilray Brands Inc — how do they compare? Prologis Inc trades at $129.49 (market cap $122.87B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: Prologis Inc is far larger — about 231.6× Tilray Brands Inc's market cap, and Prologis Inc pays a 3.31% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Prologis Inc for 102 Days and Tilray Brands Inc for 31 Days on average.
| PLD | TLRY | |
|---|---|---|
Market Cap | $122.87B | $530.54M |
Volume | 4,222,957 | 9,099,075 |
Sector | Real Estate | Health |
52-Week High | $149.96 | $21.00 |
52-Week Low | $111.23 | $3.57 |
Typical Hold Time | 102 Days | 31 Days |
Enterprise Value | $157.61B | $684.46M |
Dividend Yield | 3.31% | — |
Signals from Pluang's Aura AI — not financial advice
PLD trades at $129.49, up 1.72% today, with a bearish technical signal from moving averages but strong fundamentals including a 45.79% net income margin and three consecutive quarterly earnings beats. The stock is supported by robust leasing activity and data center growth, as highlighted in recent CFO commentary (Defense World, 2026-09-21).
The outlook is positive with a consensus price target of $155.15 (59.52% buy ratings), but risks include rising debt-to-asset ratio (37.2% in 2025) and market volatility. Upside is driven by warehouse demand and data center expansion, while macroeconomic headwinds pose challenges.
Tilray Brands (TLRY) trades at $3.50, down 5.79% on the day and near its 52-week low. The stock shows bearish technical signals with negative moving averages and recent earnings misses across four consecutive quarters. Despite revenue growth to $821 million in 2025, the company reported a substantial net loss of $2.19 billion, driven by impairment charges and high operating costs. Analyst sentiment remains cautious with 65% hold ratings, though the consensus price target of $65.01 suggests significant potential upside from current levels.
The outlook remains challenging with persistent profitability issues and negative cash flow from operations. Investment opportunity exists if Tilray can achieve projected 2026 revenue growth to $915 million and reduce losses. Key risks include ongoing operational inefficiencies, competitive pressures in the cannabis market, and regulatory uncertainty. The stock's current valuation at 0.44 P/S and 0.33 P/B may attract value investors betting on a turnaround.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →